SGN-B6A

Cat. No. M45159

All AbMole products are for research use only, cannot be used for human consumption.

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

SGN-B6A is an integrin-targeted ADC that selectively targets solid tumors by recognizing ITGB6.

Storage

Powder -20°C 3 years ; 4°C 2 years
In solvent -80°C 6 months ; -20°C 1 month

Related Integrin Products
Volociximab Volociximab (M200) is a chimeric human/murine IgG4 antibody IIA1 targeting integrin α5β1 (EC50=0.2 nM). Volociximab has antiangiogenic and antitumor activities and inhibits the proliferation of human umbilical vein vascular endothelial cells (HUVECs).
GSK 3008348 hydrochloride GSK 3008348 hydrochloride is a small molecule integrin αvβ6 antagonist.
HSDVHK-NH2 HSDVHK-NH2 is an antagonist of the integrin αvβ3-vitronectin interaction, with an IC50 of 1.74 pg/mL (2.414 pM).
LDV LDV, a tripeptide, is a non-fluorescent analog of LDV-FITC.
Cyclo(RADfK) Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.

Catalog